HitGen and the Structural Genomics Consortium entered a collaboration to discove...
Deka Biosciences has secured funding of $20m in a Series B2 financing round to a...
The FDA has set 31 March 2024 as the PDUFA action date for reviewing odronextama...
The stem cell startup aims to bolster immune systems of patients born without a ...
Karuna Therapeutics has announced the submission of a NDA to the FDA for KarXT (...
BARDA in the US has awarded a $168m Project NextGen grant to ModeX Therapeutics ...
India is known as the 'pharmacy of the world', producing a substantial quantity ...
Pharmaceutical Technology has listed some of the leading providers of washing, d...
On health care issues, the second GOP primary debate spanned drug prices, the op...
A panel of independent advisers to the FDA voted against a polarizing potential ...
The U.S. government said it would give a small biotechnology firm, Gritstone bio...
“I don’t think it was foreseeable,” a gene therapy researcher says about the dea...
Former Biogen employees said that it appeared the vast majority of the digital h...
New guidelines are needed to assure that research on human subjects performed on...
A key Brigham and Women’s executive opened up about the system’s split with Dana...
The top ranking Republican on the Senate health committee is launching an invest...
